Skip to main content
# Title Research Year
331 7. Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones 2012
332 Urinary NMP22 in bladder carcinoma: correlation with different clinicopathological features 2012
333 Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones 2012
334 Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones 2012
335 .

Identification and Estimation of Leucine Aminopaptidase Activity in the Serum and Ascitic Fluid of Patients with Schistomiasis
2011
336 Defining Patient Selectionfor Prostate-sparing Cystectomy in Squamous Cell Carcinoma of the Urinary Bladder Associated With
Bilharziasis: An Overview of 236 Patients
2011
337 Defining Patient Selectionfor Prostate-sparing Cystectomy in Squamous Cell Carcinoma of the Urinary Bladder Associated With
Bilharziasis: An Overview of 236 Patients
2011
338 Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical recurrence after transurethral resection. 2011
339 Coital incontinence: Relation to detrusor overactivity and stress incontinence. 2011
340 Defining Patient Selectionfor Prostate-sparing Cystectomy in Squamous Cell Carcinoma of the Urinary Bladder Associated With
Bilharziasis: An Overview of 236 Patients
2011